Nihon Toseki Igakkai Zasshi
Online ISSN : 1883-082X
Print ISSN : 1340-3451
ISSN-L : 1340-3451
A case of thrombotic thrombocytopenic purpura which was successfully treated with rituximab and cyclophosphamide in addition to plasma exchange and high-dose steroid therapy
Yuki EbisawaRika OhashiToshiya TakahashiTakahiko MiuraToshikazu TakizawaYoshiaki Obayashi
Author information
JOURNAL FREE ACCESS

2015 Volume 48 Issue 10 Pages 593-597

Details
Abstract
A 79-year-old man was admitted to another hospital in January 201X due to fever and eruptions. He was diagnosed with toxicodermatitis and was discharged from the hospital after steroid therapy. In April 201X, he was admitted to the hospital for thrombocytopenia, but was transferred to our hospital on suspicion of hematologic disease because of the appearance of anemia and disturbance of consciousness. Because he had thrombocytopenia, hemolytic anemia and mental confusion, he was suspected to have thrombotic thrombocytopenic purpura and immediately received plasma exchange and high-dose steroid therapy. A deficiency in ADAMTS13 activity confirmed the diagnosis of TTP later. Although improving temporarily, his laboratory tests showed recurrence of thrombocytopenia and he was administered cyclophosphamide and rituximab. Because his platelet count became stable after starting the combination therapy, PE was stopped and he was discharged from the hospital with oral steroid therapy. It was shown that rituximab and cyclophosphamide should be considered with refractory TTP.
Content from these authors
© 2015 The Japanese Society for Dialysis Therapy
Previous article Next article
feedback
Top